China Medicine Financials
| CHME Stock | USD 0.0002 0.00 0.00% |
China |
Understanding current and past China Medicine Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of China Medicine's financial statements are interrelated, with each one affecting the others. For example, an increase in China Medicine's assets may result in an increase in income on the income statement.
Please note, the presentation of China Medicine's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, China Medicine's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of China Medicine's management manipulating its earnings.
China Medicine Stock Summary
China Medicine competes with Cardinal Health, Henry Schein, Owens Minor, and Patterson Companies. China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China. CHINA MEDICINE operates under Medical Distribution classification in the United States and is traded on OTC Exchange. It employs 281 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 2F, Guangri Tower, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.cmc621.com/cmc/index.php |
| Phone | 86 20 8739 1718 |
| Currency | USD - US Dollar |
China Medicine Key Financial Ratios
There are many critical financial ratios that China Medicine's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that China Medicine reports annually and quarterly.| Return On Equity | 0.0663 | |||
| Return On Asset | 0.0782 | |||
| Number Of Employees | 281 | |||
| Beta | 36.82 | |||
| Z Score | 1.2 |
China Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining China Medicine's current stock value. Our valuation model uses many indicators to compare China Medicine value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across China Medicine competition to find correlations between indicators driving China Medicine's intrinsic value. More Info.China Medicine is rated third in return on equity category among its peers. It is number one stock in return on asset category among its peers reporting about 1.18 of Return On Asset per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the China Medicine's earnings, one of the primary drivers of an investment's value.China Medicine Systematic Risk
China Medicine's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. China Medicine volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Beta measures systematic risk based on how returns on China Medicine correlated with the market. If Beta is less than 0 China Medicine generally moves in the opposite direction as compared to the market. If China Medicine Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one China Medicine is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of China Medicine is generally in the same direction as the market. If Beta > 1 China Medicine moves generally in the same direction as, but more than the movement of the benchmark.
China Medicine December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of China Medicine help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of China Medicine. We use our internally-developed statistical techniques to arrive at the intrinsic value of China Medicine based on widely used predictive technical indicators. In general, we focus on analyzing China Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build China Medicine's daily price indicators and compare them against related drivers.
| Information Ratio | 0.1119 | |||
| Maximum Drawdown | 100.0 |
Complementary Tools for China Pink Sheet analysis
When running China Medicine's price analysis, check to measure China Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Medicine is operating at the current time. Most of China Medicine's value examination focuses on studying past and present price action to predict the probability of China Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Medicine's price. Additionally, you may evaluate how the addition of China Medicine to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |